Here are relevant reports on : central-nervous-system-drug-delivery-market
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application [Diagnostics (Clinical, PoC), Research (Proteomics, Genomics, Cell), Therapeutics (Drug Delivery Wearables)], End User – Global forecast to 2030
The global Microfluidics market, valued at US$23.71 billion in 2024, stood at US$24.96 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$37.19 billion by the end of the period. Several significant factors are driving the growth of the microfluidics market, thereby enhancing its expansion and applications. There is a growing demand for point-of-care diagnostics, which require fast, accurate, and cost-effective instruments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030
The global smart pills market, valued at US$0.61 billion in 2023, stood at US$0.69 billion in 2024 and is projected to advance at a resilient CAGR of 11.2% from 2024 to 2030, culminating in a forecasted valuation of US$1.30 billion by the end of the period. The key factors driving the market growth include technological advancements and innovative healthcare developments.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Global Forecast to 2030
The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.86 billion in 2025, at a CAGR of 15.8% during the forecast period. The report profiles key companies, including Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), AptarGroup, Inc. (US), and BD (US), which are some major players in the pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Multi-Lumen Medical Tubing Market by Material (Plastic, Rubber, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), and Country - Global Forecast to 2030
The multi-lumen medical tubing market is projected to grow from USD 8.02 billion in 2026 to USD 10.83 billion by 2030, at a CAGR of 7.8% during the forecast period. The Key Players Arkema (France), Avient Corporation (US), BASF (Germany), Celanese Corporation (US), Covestro (Germany), DuPont (US), Evonik (Germany), Lubrizol Corporation (US), Saint-Gobain Performance Plastics (France), and Solvay (Belgium).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Forecast to 2030
The Europe pharmaceutical packaging market is projected to reach USD 95.78 billion by 2030 from USD 49.24 billion in 2025, at a CAGR of 14.2% during the forecast period. German pharmaceutical packaging manufacturers are subject to some of the most stringent regulations and quality norms in Europe, as they are compliant with EU GMP, European Medicines Agency (EMA), and EU Falsified Medicines Directive (FMD). These requirements are encouraging continued investment in advanced materials, cleanroom manufacturing, and digitalized packaging technologies. The report profiles key companies, including Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Nolato AB (Sweden), and Smurfit Westrock (Ireland), which are some major players in the Europe pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market, valued at US$15.46 billion in 2025, stood at US$16.46 billion in 2026 and is projected to advance at a resilient CAGR of 6.5% from 2026 to 2031, culminating in a forecasted valuation of US$22.54 billion by the end of the period. The demand for fill-and-finish services is increasing, contributing to the growth of the injectable drug delivery market in the Middle East & Africa.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029
The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
